Home News vvdvdv vvdvdv March 19, 2008 NewsMedicine, Diagnosis, and TherapeuticsPsoriasisSkin diseasesSystemic conditionsTakeda Pharmaceutical Company Also of Interest HIV-Free Hopes Raised by Reservoir-Targeting VLPs Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Culprit behind Psoriasis Revealed Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline StockWatch: CDMOs Tumble as Congress Takes Aim at Chinese Biotechs StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug Related Media Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Emerging Markets Collaborate to Succeed in Post-Pandemic World Breathing Oxygen Back into the Biological Conversation Global Single-Use Network Support Assurance of Supply Resins Address Downstream Purification Concerns Materials Sourcing: Precautions and Improvements for Cell and Gene Therapies Related Content HIV-Free Hopes Raised by Reservoir-Targeting VLPs Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Culprit behind Psoriasis Revealed Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline